By Arasu Kannagi Basil (Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

Maze Therapeutics is eyeing a $113 million initial public offering a little under two months after revealing a $115 million ...

An international team of scientists have discovered that soap could be important to helping our understanding of complex ...

An anonymous coder, writing to 404media under the fake name Aaron B, has also been feeling the malaise, and he's doing ...

One unsung jump scare game in particular pioneered horror in the internet age, blazing everywhere from nascent social media ...